$PRPO Precipio Inc Target PTs 11 --> 6.20 --> 14.80 and higher
PRPO
Precipio Inc Target PTs 11 --> 6.20 --> 14.80 and higher
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.